About Forma Therapeutics
Forma Therapeutics is a company based in Watertown (United States) founded in 2007 was acquired by Novo Nordisk in September 2022.. Forma Therapeutics has raised $417.55 million across 8 funding rounds from investors including Novartis, Novo Nordisk and Janus Henderson Investors. The company has 165 employees as of December 31, 2021. Forma Therapeutics offers products and services including Ozempic. Forma Therapeutics operates in a competitive market with competitors including Jazz Pharmaceuticals, Denali Therapeutics, C4 Therapeutics, Erasca and Revolution Medicines, among others.
- Headquarter Watertown, United States
- Employees 165 as on 31 Dec, 2021
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Novo Nordisk A/S
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$417.55 M (USD)
in 8 rounds
-
Latest Funding Round
$100 M (USD), Series D
Dec 19, 2019
-
Investors
Novartis
& 10 more
-
Employee Count
165
as on Dec 31, 2021
-
Acquired by
Novo Nordisk
(Sep 01, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Forma Therapeutics
Forma Therapeutics offers a comprehensive portfolio of products and services, including Ozempic. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Medication for managing type 2 diabetes and improving patient outcomes.
Unlock access to complete
Unlock access to complete
Funding Insights of Forma Therapeutics
Forma Therapeutics has successfully raised a total of $417.55M across 8 strategic funding rounds. The most recent funding activity was a Series D round of $100 million completed in December 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Series D — $100.0M
-
First Round
First Round
(18 Mar 2008)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2019 | Amount | Series D - Forma Therapeutics | Valuation | RA Capital Management | |
| Feb, 2017 | Amount | Grant - Forma Therapeutics | Valuation |
investors |
|
| Apr, 2014 | Amount | Series D - Forma Therapeutics | Valuation | Celgene |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Forma Therapeutics
Forma Therapeutics has secured backing from 11 investors, including institutional and venture fund investors. Prominent investors backing the company include Novartis, Novo Nordisk and Janus Henderson Investors. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital funding is provided by Samsara BioCapital in California.
|
Founded Year | Domain | Location | |
|
Multiple sectors are targeted for venture capital investments.
|
Founded Year | Domain | Location | |
|
Early-stage life sciences investments are targeted in the healthcare sector.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Forma Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Forma Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Forma Therapeutics Comparisons
Competitors of Forma Therapeutics
Forma Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Denali Therapeutics, C4 Therapeutics, Erasca and Revolution Medicines, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| domain | founded_year | HQ Location |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Forma Therapeutics
Frequently Asked Questions about Forma Therapeutics
When was Forma Therapeutics founded?
Forma Therapeutics was founded in 2007 and raised its 1st funding round 1 year after it was founded.
Where is Forma Therapeutics located?
Forma Therapeutics is headquartered in Watertown, United States.
Who is the current CEO of Forma Therapeutics?
Frank Lee is the current CEO of Forma Therapeutics.
Is Forma Therapeutics a funded company?
Forma Therapeutics is a funded company, having raised a total of $417.55M across 8 funding rounds to date. The company's 1st funding round was a Series D of $225M, raised on Mar 18, 2008.
How many employees does Forma Therapeutics have?
As of Dec 31, 2021, the latest employee count at Forma Therapeutics is 165.
What does Forma Therapeutics do?
Forma Therapeutics was founded in 2007 and is based in Watertown, United States. Operations focus on biotechnology, where drug discovery engines are utilized to screen and apply structure-based methods across targets in tumor metabolism, epigenetics, protein homeostasis, and protein-protein interactions. Lead candidates such as FT-4202 for sickle cell disease, FT-7051 for acute myeloid leukemia, and olutasidenib for glioma are advanced through development pipelines.
Who are the top competitors of Forma Therapeutics?
Forma Therapeutics's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.
What products or services does Forma Therapeutics offer?
Forma Therapeutics offers Ozempic.
Who are Forma Therapeutics's investors?
Forma Therapeutics has 11 investors. Key investors include Novartis, Novo Nordisk, Janus Henderson Investors, RA Capital, and Celgene.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.